GLP Watchdog

Fridays vs Hims

Hims has an open FDA warning letter dated September 9, 2025. Fridays has none. No price lines up like for like. They share brand-name semaglutide pen, but Hims' $199 covers the medication only, with a separate membership on top.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Hims

Fridays logo

Fridays

5.8/10

Hims logo

Hims

6.7/10

FDA warning letters
None on record
Pharmacy
Lowest standing price
$249/moCompounded semaglutide injection
$149/moBrand-name semaglutide pill, medication only, membership extra
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Fridays
Visit Hims

Neither Fridays nor Hims pays us. Links to them earn nothing. Scores: Fridays 5.8, Hims 6.7. How we are paid

What the record shows

  1. 01

    Hims has an open FDA warning letter dated September 9, 2025. Fridays has none.

  2. 02

    Fridays names four pharmacies. Hims sells brand-name medication only.

  3. 03

    No price lines up like for like. They share brand-name semaglutide pen, but Hims' $199 covers the medication only, with a separate membership on top.

  4. 04

    Only Fridays lists a price for compounded semaglutide injection and compounded tirzepatide injection. Only Hims lists a price for brand-name semaglutide pill and Foundayo (orforglipron) pill.

  5. 05

    Hims lists all 50 states. Fridays publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Hims

Brand-name semaglutide pen

$1,498/mo

$17,976 a year

$199/mo

medication only, membership extra; not compared

Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

$299/mo

medication only, membership extra; not compared

Compounded semaglutide injection

$249/mo

$2,988 a year

Not sold or not priced
Compounded tirzepatide injection

$359/mo

$4,308 a year

Not sold or not priced
Brand-name semaglutide pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Foundayo (orforglipron) pill
Not sold or not priced

$149/mo

medication only, membership extra; not compared

Price includes
Medication, clinician visits, coaching
Medication
Billed separately
Not stated
Clinician visits, coaching
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
Monthly membership, auto-renews
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
First month's membership fee is non-refundable; partial-period refunds are not guaranteed
Early-exit fee
Not stated
None stated

Read off each seller’s own pages. Fridays: October 30, 2026. Hims: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • No FDA warning letter on record
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Hims does not price
  • Price includes clinician visits and coaching
  • Publishes no state list
Visit Fridays

The case for Hims

6.7/10
  • Sells brand-name semaglutide pill and Foundayo (orforglipron) pill, which Fridays does not price
  • Open FDA warning letter, September 9, 2025
  • Price leaves out clinician visits and coaching
  • Lowest price covers the medication only, with a separate membership on top
Visit Hims

Scores

Fridays 5.8 · Hims 6.7 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

5.5A
vs
B
6.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
3.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Hims: questions

Hims has an open FDA warning letter dated September 9, 2025. Fridays has none. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Hims sells brand-name medication only. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share brand-name semaglutide pen, but Hims' $199 covers the medication only, with a separate membership on top. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Hims states you can cancel at any time; refunds: first month's membership fee is non-refundable; partial-period refunds are not guaranteed.
Neither Fridays nor Hims pays us. Links to them earn nothing. Scores: Fridays 5.8, Hims 6.7.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks